Intellia Therapeutics

+$3.44 (+2.24%) Today
$0.00 (0.00%) As of 11:05 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell NTLA and other ETFs, options, and stocks.

About NTLA

Intellia Therapeutics, Inc. is a clinical stage genome editing company, which engages in the development of curative therapeutics using the CRISPR/Cas9 system. Its CRISPR/Cas9 system transforms medicine by both producing therapeutics that permanently edit and/or correct disease-associated genes in the human body with a single treatment course, and creates engineered cells that can treat oncological and immunological diseases.

CEO
John M. Leonard
Employees
312
Headquarters
Cambridge, Massachusetts
Founded
2014

NTLA Key Statistics

Market Cap
11.56B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
821.43K
High Today
$158.84
Low Today
$145.79
Open Price
$156.02
Volume
1.76M
52 Week High
$202.73
52 Week Low
$18.81

NTLA Earnings

-$1.01
-$0.67
-$0.34
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 4, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure